A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet
Clinical trial NCT07285967 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07285967
- Sponsor
- Hangzhou Yirui Pharmaceutical Technology Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2027-04-01
- Primary completion
- 2027-09-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.